Literature DB >> 18719061

Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity?

Diab Mutlak1, Doron Aronson1, Jonathan Lessick1, Shimon A Reisner1, Salim Dabbah1, Yoram Agmon2.   

Abstract

BACKGROUND: Pulmonary hypertension is a common cause of functional tricuspid regurgitation (TR), but other factors play a role in determining TR severity. The objectives of our study were to determine the distribution of TR severity in relation to pulmonary artery systolic pressure (PASP) and to define the determinants of TR severity.
METHODS: The echocardiographic reports and selected echocardiographic studies of patients with echocardiographic estimation of PASP were reviewed. Patients with organic tricuspid valve (TV) disease were excluded from the analysis.
RESULTS: Among 2,139 patients, the frequency of moderate or severe TR was progressively greater in patients with higher PASP. Nevertheless, TR was only mild in a substantial proportion of patients with high PASP (mild TR in 65.4% of patients with PASP 50-69 mm Hg and in 45.6% of patients with PASP >or= 70 mm Hg). By multivariate analysis, age, female gender, PASP (odds ratio, 2.26 per 10-mm Hg increase; 95% confidence interval, 1.95 to 2.61), pacemaker lead, right atrial (RA) and right ventricular enlargement, left atrial enlargement, and organic mitral valve disease were independently associated with greater degrees of TR. In patients with PASP >or= 70 mm Hg, RA size, tricuspid annular diameter, and TV tethering area were greater in patients with greater degrees of TR.
CONCLUSIONS: PASP is a strong determinant of TR severity, but many patients with pulmonary hypertension do not exhibit significant TR. In addition to PASP, demographic characteristics, mechanical factors, remodeling of the right heart cavities, and other factors (possibly reflecting the presence of atrial fibrillation or occult organic TV disease) are predictive of TR severity.

Entities:  

Mesh:

Year:  2008        PMID: 18719061     DOI: 10.1378/chest.08-0277

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  40 in total

Review 1.  Tricuspid regurgitation: pathophysiology and management.

Authors:  Rashmi Thapa; Buddhadeb Dawn; Jayant Nath
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

2.  Leaflet area as a determinant of tricuspid regurgitation severity in patients with pulmonary hypertension.

Authors:  Jonathan Afilalo; Julia Grapsa; Petros Nihoyannopoulos; Jonathan Beaudoin; J Simon R Gibbs; Richard N Channick; David Langleben; Lawrence G Rudski; Lanqi Hua; Mark D Handschumacher; Michael H Picard; Robert A Levine
Journal:  Circ Cardiovasc Imaging       Date:  2015-05       Impact factor: 7.792

3.  Impact of implantable transvenous device lead location on severity of tricuspid regurgitation.

Authors:  Karima Addetia; Francesco Maffessanti; Anuj Mediratta; Megan Yamat; Lynn Weinert; Joshua D Moss; Hemal M Nayak; Martin C Burke; Amit R Patel; Eric Kruse; Valluvan Jeevanandam; Victor Mor-Avi; Roberto M Lang
Journal:  J Am Soc Echocardiogr       Date:  2014-08-14       Impact factor: 5.251

Review 4.  [Medicinal treatment of tricuspid valve regurgitation].

Authors:  M Lankeit; K Keller; C Tschöpe; B Pieske
Journal:  Herz       Date:  2017-11       Impact factor: 1.443

5.  Predictors of severe tricuspid regurgitation in patients with permanent pacemaker or automatic implantable cardioverter-defibrillator leads.

Authors:  Mohammad Q Najib; Satya S Vittala; Suresh Challa; Amol Raizada; Fernando J Tondato; Howard R Lee; Hari P Chaliki
Journal:  Tex Heart Inst J       Date:  2013

6.  Force Required to Cinch the Tricuspid Annulus: An Ex-Vivo Study.

Authors:  Amy Adkins; Jesus Aleman; Lori Boies; Edward Sako; Shamik Bhattacharya
Journal:  J Heart Valve Dis       Date:  2015-09

Review 7.  Tricuspid regurgitation after successful mitral valve surgery.

Authors:  Vasiliki Katsi; Leonidas Raftopoulos; Constantina Aggeli; Ioannis Vlasseros; Ioannis Felekos; Dimitrios Tousoulis; Christodoulos Stefanadis; Ioannis Kallikazaros
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-28

8.  Independent evaluation of a simple clinical prediction rule to identify right ventricular dysfunction in patients with shortness of breath.

Authors:  Frances M Russell; Christopher L Moore; D Mark Courtney; Christopher Kabrhel; Howard A Smithline; Kristen E Nordenholz; Peter B Richman; Brian J O'Neil; Michael C Plewa; Daren M Beam; Ronald Mastouri; Jeffrey A Kline
Journal:  Am J Emerg Med       Date:  2015-01-22       Impact factor: 2.469

9.  The value of hepatic diffusion-weighted MR imaging in demonstrating hepatic congestion secondary to pulmonary hypertension.

Authors:  Yuksel Dogan; Aliye Soylu; Ozgur Kilickesmez; Tuna Demirtas; Kadriye Orta Kilickesmez; Sebahat Nacar Dogan; Gulay Eren; Isa Sevindir; Nurgul Yasar; Sule Poturoglu; Kenan Sonmez
Journal:  Cardiovasc Ultrasound       Date:  2010-07-21       Impact factor: 2.062

10.  Right ventricle performances with echocardiography and 99mTc myocardial perfusion imaging in pulmonary arterial hypertension patients.

Authors:  Jie Liu; Lei Fei; Guang-Qing Huang; Xiao-Ke Shang; Mei Liu; Zhi-Jun Pei; Yong-Xue Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.